This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (70)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Georges E. Chalkiadakis, MD; Alkiviadis Kostakis, MD; Panayotis E. Karayannacos, MD; Maria E. Chalkiadakis, MSc; Stella Sgouromali, MD; Helen Giamarellou, MD; Gregory D. Skalkeas, MD

Arch Surg. 1985;120(10):1141-1144.

Abstract
• The objective of this study was to determine the effect of pentoxifylline on the clinical and pathologic course of experimentally induced peritonitis in rats. This drug is a methyxanthine derivative that has vasodilating properties and may decrease platelet aggregation. Peritonitis was induced in 40 Wistar rats by creating a closed ileal loop 4 cm long 5 cm from the ileocecal valve. The animals were divided into two groups of 20 animals each. The first group served as controls, while each animal of the second group received 17 mg/kg/day of pentoxifylline intramuscularly from the day of operation until 30 days postoperatively. The survival rate was significantly Increased in the group receiving pentoxifylline and adhesion or abscess formation was considerably reduced. We concluded that the administration of pentoxifylline prolongs significantly the survival of animals with experimental peritonitis and reduces the development of adhesions and abscesses in the peritoneal cavity. This beneficial effect may be attributed to decreased fibrinogen deposits and increased fibrinolytic activity within the peritoneal cavity, thus rendering the bacteria more susceptible to cellular and noncellular clearing mechanisms.

(Arch Surg 1985;120:1141-1144)

Author Affiliations
From the Laboratory for Experimental Surgery and Surgical Research, Second Department of Propedeutic Surgery, Athens (Greece) University School of Medicine.

Footnotes
Accepted for publication June 4, 1985.

Reprint requests to Sevastopoulou, 6, Ano Ambelokipi, 11524 Athens, Greece (Dr Chalkiadakis).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pentoxifylline prevents the transition from the hyperdynamic to hypodynamic response during sepsis
Yang et al.
Am. J. Physiol. Heart Circ. Physiol. 1999;277:H1036-H1044.
ABSTRACT | FULL TEXT  

VESNARINONE AND AMRINONE REDUCE THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
Takeuchi et al.
J. Thorac. Cardiovasc. Surg. 1999;117:375-382.
ABSTRACT | FULL TEXT  

Pentoxifylline Inhibits TNF-alpha Production from Human Alveolar Macrophages
MARQUES et al.
Am. J. Respir. Crit. Care Med. 1999;159:508-511.
ABSTRACT | FULL TEXT  

Effect of Pentoxifylline in Severe Sepsis: Results of a Randomized, Double-blind, Placebo-Controlled Study
Staubach et al.
Arch Surg 1998;133:94-100.
ABSTRACT | FULL TEXT